Vis enkel innførsel

dc.contributor.authorAdlard, Bryan
dc.contributor.authorLemire, Mélanie
dc.contributor.authorBonefeld-Jørgensen, Eva Cecilie
dc.contributor.authorLong, Manhai
dc.contributor.authorÓlafsdóttir, Kristín
dc.contributor.authorOdland, Jon Øyvind
dc.contributor.authorRautio, Arja
dc.contributor.authorMyllynen, Päivi
dc.contributor.authorSandanger, Torkjel M
dc.contributor.authorDudarev, Alexey A.
dc.contributor.authorBergdahl, Ingvar A.
dc.contributor.authorWennberg, Maria
dc.contributor.authorBerner, James
dc.contributor.authorAyotte, Pierre
dc.date.accessioned2021-07-05T11:29:10Z
dc.date.available2021-07-05T11:29:10Z
dc.date.issued2021-06-03
dc.description.abstractExposure to mercury (Hg) is a global concern, particularly among Arctic populations that rely on the consumption of marine mammals and fish which are the main route of Hg exposure for Arctic populations.The MercuNorth project was created to establish baseline Hg levels across several Arctic regions during the period preceding the Minamata Convention. Blood samples were collected from 669 pregnant women, aged 18–44 years, between 2010 and 2016 from sites across the circumpolar Arctic including Alaska (USA), Nunavik (Canada), Greenland, Iceland, Norway, Sweden, Northern Lapland (Finland) and Murmansk Oblast (Russia). Descriptive statistics were calculated, multiple pairwise comparisons were made between regions, and unadjusted linear trend analyses were performed.Geometric mean concentrations of total Hg were highest in Nunavik (5.20 µg/L) and Greenland (3.79 µg/L), followed by Alaska (2.13 µg/L), with much lower concentrations observed in the other regions (ranged between 0.48 and 1.29 µg/L). In Nunavik, Alaska and Greenland, blood Hg concentrations have decreased significantly since 1992, 2000 and 2010 respectively with % annual decreases of 4.7%, 7.5% and 2.7%, respectively.These circumpolar data combined with fish and marine mammal consumption data can be used for assessing long-term Hg trends and the effectiveness of the Minamata Convention.en_US
dc.identifier.citationAdlard B, Lemire M, Bonefeld-Jørgensen EC, Long M, Ólafsdóttir K, Odland j, Rautio A, Myllynen P, Sandanger TM, Dudarev AA, Bergdahl IA, Wennberg M, Berner J, Ayotte P. MercuNorth – monitoring mercury in pregnant women from the Arctic as a baseline to assess the effectiveness of the Minamata Convention. International Journal of Circumpolar Health. 2021;80en_US
dc.identifier.cristinIDFRIDAID 1919994
dc.identifier.doi10.1080/22423982.2021.1881345
dc.identifier.issn1239-9736
dc.identifier.issn2242-3982
dc.identifier.urihttps://hdl.handle.net/10037/21740
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.relation.journalInternational Journal of Circumpolar Health
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2021 The Author(s)en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Community medicine, Social medicine: 801en_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801en_US
dc.titleMercuNorth – monitoring mercury in pregnant women from the Arctic as a baseline to assess the effectiveness of the Minamata Conventionen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel